Blog Posts

340B Reform Could Generate Federal Savings, Says Consulting Firm That Has Conducted 340B Studies for Pharma Friendly Groups

Avalere's Milena Sullivan told 340B Report that it's important to understand "the impact 340B reform could have on federal spending."
A federal legislative overhaul of the 340B program could provide Medicare savings for the federal government, according to a review [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Five Manufacturers Announce Refunds to 340B Providers

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.
Five drugmakers have issued recent refund notices to 340B covered entities for drug overcharges. In letters posted on the website [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Key House Hearing Intensifies Debate on 340B’s Future Amid Multiple Major Reform Efforts

Rep. Morgan Griffith (R-VA), chairman of the House Energy and Commerce Oversight and Investigations Subcommittee, speaks at a hearing on June 4, 2024.
A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Minnesota Is Seventh State to Enact 340B Contract Pharmacy Law, State Also Expands Covered Entity Reporting

Minnesota Gov. Tim Walz (D) signed a law to prohibit drugmaker 340B contract pharmacy restrictions in the state.
Minnesota became the 7th state to enact a law to protect distribution of 340B drugs through contract pharmacies when the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New York Unlikely to Move 340B Contract Pharmacy, PBM Protections Bill in 2024, Sponsors Say

New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers' and pharmacy benefit managers' (PBMs) policies against covered entities and N.Y. pharmacies based on their 340B participation.
New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers and pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Follows PhRMA in Seeking to Block Mississippi 340B Contract Pharmacy Law

Drugmaker Novartis has filed the second lawsuit challenging Mississippi's 340B contract pharmacy access law.
Drugmaker Novartis recently filed the second lawsuit that seeks to block implementation and enforcement of a recently enacted Mississippi law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

BMS Requires Re-Designation of 340B Contract Pharmacies and New Requirements Intended to Prevent Alternative Distribution Models

Drug manufacturer BMS updated its 340B contract pharmacy restrictions to require pharmacies to re-register by June 21 and add additional requirements.
Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, requiring registered sites to be [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sobi Becomes 34th Drugmaker to Implement Contract Pharmacy Restrictions, Exelixis Tightens Contract Pharmacy Policy

Exelixis wordmark building-mounted sign
California-based Exelixis, a specialty manufacturer with two high-priced drug products on the market, announced it is further restricting contract pharmacy access to 340B hospitals in a May 31 letter published on 340B ESP. 
Swedish biopharmaceutical company Sobi announced this week that beginning July 1 it will implement 340B contract pharmacy restrictions, making the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Expert Tip from The Alinea Group

img
img

TIP: Don’t assume your contract pricing is correct on every account just because it’s correct on one account.


Read More »

News Alert

In Key Hearing, GOP Lawmakers Raise Concerns About 340B Growth and Hospital Use While Democrats Urge Caution

Sue Veer, president and CEO, Carolina Health Centers, speaks at the House Energy and Commerce Committee's Oversight and Investigations Subcommittee hearing on June 4, 2024.
340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live